Siga Technologies (SIGA) Change in Receivables (2010 - 2025)
Siga Technologies' (SIGA) quarterly Change in Receivables came in at -$4.0 million in Q3 2025, down 227.49% YoY from $3.1 million in Q3 2024, and down 471.61% on a QoQ basis from -$699108.0 in Q2 2025.
Siga Technologies (SIGA) Change in Receivables (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has 16 years of Change in Receivables data on file, last reported at -$4.0 million in Q3 2025.
- Quarterly Change in Receivables fell 227.49% year-over-year to -$4.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$9.6 million (down 337.66% YoY) and the FY2024 annual result came in at $35178.0, up 100.14% from the prior year.
- Change in Receivables retreated to -$4.0 million in Q3 2025, from -$699108.0 in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $79.8 million in Q4 2021 to a low of -$78.3 million in Q1 2022.
- A 5-year average of -$44738.4 and a median of -$699108.0 in 2025 frame the typical range for Change in Receivables.
- The widest YoY moves for Change in Receivables: up 1144.17% in 2022, down 11947.51% in 2022.
- Tracing SIGA's Change in Receivables over 5 years: stood at $79.8 million in 2021, then sank by 111.92% to -$9.5 million in 2022, then jumped by 237.42% to $13.1 million in 2023, then slumped by 30.61% to $9.1 million in 2024, then plunged by 144.02% to -$4.0 million in 2025.
- The last three Change in Receivables figures came in at -$4.0 million (Q3 2025), -$699108.0 (Q2 2025), and -$14.0 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Siga Technologies | 210.16 Mn | 55.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -4.00 Mn |
| Sep 30, 2025 | -4.00 Mn |
| Jun 30, 2025 | -699,108.00 |
| Jun 30, 2025 | -699,108.00 |
| Mar 31, 2025 | -13.98 Mn |
| Mar 31, 2025 | -13.98 Mn |
| Dec 31, 2024 | 9.08 Mn |
| Dec 31, 2024 | 9.08 Mn |
| Sep 30, 2024 | 3.13 Mn |
| Sep 30, 2024 | 3.13 Mn |
| Jun 30, 2024 | -9.17 Mn |
| Jun 30, 2024 | -9.17 Mn |
| Mar 31, 2024 | -3.00 Mn |
| Mar 31, 2024 | -3.00 Mn |
| Dec 31, 2023 | 13.08 Mn |
| Dec 31, 2023 | 13.08 Mn |
| Sep 30, 2023 | 2.02 Mn |
| Sep 30, 2023 | 2.02 Mn |
| Jun 30, 2023 | -6.29 Mn |
| Jun 30, 2023 | -6.29 Mn |